Advil Ibuprofen Tablets Recalled for Storage Temperature Deviation
Family Dollar Stores is recalling Advil Ibuprofen 200 mg tablets due to a storage temperature deviation during manufacturing and distribution. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a CGMP storage temperature deviation that could affect product quality, but without evidence of actual harm, it qualifies as a precautionary recall.
Plain-English summary
Family Dollar Stores, Llc. is recalling Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer, in three packaging formats: 100-count bottles, 50-count bottles, and multi-packs of 3 packets (2 tablets per packet). The recalled product was distributed nationwide between July 28, 2022 and March 31, 2023.
The recall stems from a Current Good Manufacturing Practice (CGMP) deviation: the product was stored and distributed outside the labeled storage temperature requirements during the manufacturing and distribution process.
No illnesses or injuries have been reported in connection with this recall. Consumers with the recalled product should stop using it.
The recalled product
- Product
- Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-count bottles, b) 50-count bottles, and c) 3 (2 count) packets.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Pain Reliever
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs a) 0901458
- b) 0913023
- c) 0999259 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27